Oaktree Acquisition III Life Sciences EBITDA 2025-2024 | OACC

Oaktree Acquisition III Life Sciences ebitda from 2025 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Oaktree Acquisition III Life Sciences Annual EBITDA
(Millions of US $)
Oaktree Acquisition III Life Sciences Quarterly EBITDA
(Millions of US $)
2024-09-30
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
Aduro Clean Technologies (ADUR) Canada $0.179B 0.00
Tavia Acquisition (TAVI) $0.138B 0.00
Youxin Technology (YAAS) $0.096B 0.00
YSX Tech (YSXT) $0.091B 0.00
Leishen Energy Holding (LSE) $0.087B 0.00
YHN Acquisition I (YHNA) $0.080B 0.00
New Century Logistics (BVI) (NCEW) $0.051B 0.00
Sky Quarry (SKYQ) $0.022B 0.00